Neogenomics, Inc. Earnings

Neogenomics, Inc.’s revenue jumped 10.23% since last year same period to $181.33Mn in the Q2 2025. On a quarterly growth basis, Neogenomics, Inc. has generated 7.91% jump in its revenue since last 3-months.

Neogenomics, Inc.’s net profit fell -141.88% since last year same period to $-45.09Mn in the Q2 2025. On a quarterly growth basis, Neogenomics, Inc. has generated -73.95% fall in its net profits since last 3-months.

Neogenomics, Inc.’s net profit margin fell -119.44% since last year same period to -24.87% in the Q2 2025. On a quarterly growth basis, Neogenomics, Inc. has generated -61.19% fall in its net profit margins since last 3-months.

Neogenomics, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.02 - a 4% jump from last quarter’s estimates.

Neogenomics, Inc.’s earning per share (EPS) estimates for the current year stand at 0.02.

Neogenomics, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Neogenomics, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.